Gain Therapeutics
GANX
GANX
23 hedge funds and large institutions have $3.95M invested in Gain Therapeutics in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$202K | |
| 2 | +$82K | |
| 3 | +$78K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$41K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$39K |
Top Sellers
| 1 | -$32.6K | |
| 2 | -$7.22K | |
| 3 | -$2.1K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$330 |